Introduction

Oral squamous cell carcinoma represents about 1–3 % of all human cancers, and is the 6th most frequent cancer in the world [1, 2]. Oral squamous cell carcinoma continues to show a poor prognosis and remains a lethal disease for more than 50 % of cases diagnosed annually [3]. In particular, its invasion potential is strongly related to its poor prognosis [4, 5]. Some investigators have demonstrated that a high malignancy grade of the deep invasive front had predictive value for neck regional lymph node metastasis [6] and prognosis [7, 8] in oral squamous cell carcinoma; therefore, elucidation of the mechanisms underlying invasion and a novel therapeutic strategy should be developed to improve the outcome of patients with oral squamous cell carcinoma.

MicroRNAs (miRNAs) are small non-coding RNAs of 18–25 nucleotides in length that have a crucial role in post-transcriptional regulation of gene expression [9]. By base-pairing to the 3′-untranslated region (3′-UTR) of target mRNAs, the mature miRNA is incorporated into the RNA-induced silencing complex (RISC) where it mediates gene expression by binding to target mRNA [9, 10]. Dysregulation of miRNAs in cancer has been shown to associate with various tumor characteristics and prognosis in a variety of cancers, including the oral cavity [1113]. Several miRNAs have been functionally classified as proto-oncogenes or tumor suppressors, and contribute to tumor initiation and progression by promoting uncontrolled proliferation, favoring survival and/or promoting invasive behavior [11, 12].

In particular, microRNA-21 (miR-21) is the oncogenic miRNA upregulated in most types of cancer, including breast, colon, lung, pancreas, prostate, stomach, hepatocellular, ovarian, cervical, head and neck, and leukemia [1416]. Recently, some authors have reported that miR-21 expression would be a useful biomarker associated with a worse outcome [17, 18]. Previous studies have shown that miR-21 may have a role in invasion and metastasis by several target molecules [1922]; however, little is known as to how miR-21 affects the mechanism of OSCC invasion. Thus, in this study we focused on the correlation of miR-21 expression with tumor invasion, and the role of miR-21 in the biological behavior in OSCC. Finally, we showed that miR-21 promoted oral cancer invasion by down-regulating Wnt antagonist gene Dickkopf 2 (DKK2).

Materials and Methods

Patients

Paraffin-embedded sections were obtained from biopsy specimens of 79 patients with squamous cell carcinoma of the tongue who underwent radical surgery in our department between April 1996 and March 2005. The tumor stage was classified according to the TNM classification of the International Union Against Cancer. Tumor histologic differentiation was defined according to the WHO classification. The pattern of invasion was classified according to Bryne’s classification [7].

Cell Line

The human tongue cancer cell line SCC25, obtained from the American Type Culture Collection (Manassas, VA), was cultured in a 1:1 mixture of Ham’s F-12/DMEM supplemented with 10 % fetal bovine serum at 37 °C in the presence of 5 % CO2.

In Situ MiR-21 Hybridization

Serial sections 4 μm thick were taken from the tissue blocks. Deparaffinized sections in xylene were rinsed in sterile H2O, pretreated with 15 μg/ml proteinase K for 8 min at 37 °C, washed three times with sterile H2O, submerged in 95 % ethanol for 1 min, and air-dried completely. Sections were then hybridized in humidified chambers overnight at 37 °C using a 20 nM locked nucleic acid (LNA) probe diluted with hybridization buffer (BioGenex, San Ramon, CA). Digoxigenin (DIG)-labeled miRCULY LNA miRNA detection probes (Exiqon, Vedbaek, Denmark) were used in this study. The sequences of the miR-21 probe and the scramble control probe as the negative control were 5′-TCAACATCAGTCTGATAAGCTA-3′ and 5′-CATTATGTCGGACAACTCAAT-3′, respectively. After incubation, sections were placed in room temperature 5x SSC. Stringent washing was performed at 37 °C: one in 5× SSC, twice in 1x SSC and twice in 0.2× SSC. Sections were blocked against unspecific binding of the detecting antibody using DIG wash and blocking reagent (DIG Wash and Block Buffer Set; Roche, Mannheim, Germany). Alkaline phosphatase (AP)-conjugated anti-DIG (Roche) was diluted 1:800 in blocking solution and incubated for 2 hs at 30 °C. The sections were washed with PBS, stained with 4-nitro-blue tetrazolium (NBT)/5-brom-4-chloro-3′-indolylphosphate (BCIP) substrate ready-to-use tablet (Roche), and counterstained with nuclear fast red (Vector Laboratories, Burlingame, CA). Finally, the sections were dehydrated through an increasing gradient of ethanol solutions and mounted with Eukitt mounting medium (VWR, Herlev, Denmark).

Each slide was scored by 2 blinded, independent pathologists. To detect miR-21, each TMA spot was scanned and scored based on hybridization intensity (0: negative, 1: weak, 2: strong) and the percent of positive epithelial cells detected (0: <1 %, 1: focal, 1 % to 50 %, 2: diffuse, greater than 50 %). An ISH score for each lesion was calculated by multiplying the intensity by the area [23]. This was classified as 0: negative vs. ≥1: positive, representing low vs. high miR-21 expression. This relatively simple, reproducible scoring method provided highly concordant results between independent evaluators.

MiR-21 Target Prediction

To determine the miR-21 target, we searched for molecular genes involved in tumor invasion using a commonly cited prediction program miRanda (http://www.microrna.org; August 2010 release), which is a comprehensive resource of microRNA target and expression profiles. Prediction scores were computed using the miRanda database of highly conserved target sites with good mirSVR scores.

Immunohistochemical Staining

Serial sections 4 μm thick were taken from the tissue blocks. Deparaffinized sections in xylene were soaked in 10 mM citrate buffer (pH 6) and placed in an autoclave at 121 °C for 5 min for antigen retrieval. Endogenous peroxidase was blocked using 0.3 % H2O2 in methanol for 30 min. Immunohistochemistry was performed by the EnVision method (EnVision+, DAKO, Glostrup, Denmark). The primary antibodies used were directed against E-cadherin (#4065; Cell Signaling Technology, Danvers, MA; 1:50 dilution), β-catenin (#9562; Cell Signaling Technology; 1:50 dilution), and DKK2 (ab38594; Abcam, Cambridge, UK; 1:50 dilution). The sections were incubated with the antibodies overnight at 4 °C. Reaction products were visualized by immersing the sections in diaminobenzidine (DAB) solution, and the samples were counterstained with Myer’s hematoxylin and mounted. The expression was evaluated by calculating the total immunostaining score as the product of the proportion score and the intensity score. The proportion score described the estimated fraction of positive-stained tumor cells (0: none, 1: <10 %, 2: 10–50 %, 3: 50–80 %, 4: >80 %). The intensity score represented the estimated staining intensity (0: no staining, 1: weak, 2: moderate, 3: strong). The total score ranged from 0 to 12. As described previously [24], positive expression was defined as a total score >4.

Knockdown of MiR-21 with Anti-Sense LNA Oligomers

miRCURY LNA knockdown probes for miR-21 (miRCURY LNA microRNA Power Inhibitor, has-miR-21, product sequence is CAACATCAGTCTGATAAGCT), and for control miRNA (miRCURY LNA microRNA Power Inhibitor control, Negative Control A, product sequence is GTGTAACACGTCTATACGCCCA) LNA probes as a negative control were purchased from Exiqon, Inc. Cells were transfected with LNA probes using Oligofectamine reagent (Invitrogen) according to the manufacturer’s protocol. The SCC25 tongue cancer cell line was used for this experiment. Briefly, 2.5 × 104 SCC25 cells were plated in each well of six-well plates and allowed to grow for 24 h (until they were approximately 50 % confluent). LNA probe was then transfected into cells using Oligofectamine reagent and serum-free medium. After 4-h incubation, serum-rich medium was added.

Real Time RT-PCR

Cells were harvested and total RNA was extracted 72 h after transfection as previously described [24]. Total RNA was isolated from transfected cells using TRIzol reagent (Invitrogen) according to the manufacturer’s protocol. Then, cDNA synthesis was performed using a Universal cDNA synthesis kit (Exiqon). cDNA served as a template for microRNA quantitative real-time PCR using the miRCURY LNA Universal RT microRNA PCR kit (Exiqon). Primers included Exiqon-validated miR-21 specific primer sets (hsa-miR-21 primer, target sequence is CAACACCAGUCGAUGGGCUGU) and GAPDH control primers (Life Technologies, Carlsbad, CA). qPCR assays were performed using the Mx3000P QPCR System (Agilent Technologies, Santa Clara, CA).

Western Blotting

Cells were harvested and protein was extracted 72 h after transfection as previously described [24]. Total cell lysates were purified using a Mammalian cell extraction kit (BioVision, Mountain View, CA). All subsequent manipulations were performed on ice. The protein concentration of each sample was measured with micro-BCA protein assay reagent (Pierce Chemical Co., Rockford, IL). The samples were denatured in SDS sample buffer and loaded onto12.5 % polyacrylamide gels. After electrophoresis, the proteins were transferred onto a polyvinylidine difluoride membrane and immunoblotted with DKK2 (ab38594; Abcam). The signal was detected using the horseradish peroxidase-conjugated secondary antibody (Amersham Biosciences, Piscataway, NJ), and then visualized using an ECL Kit (Amersham Pharmacia Biotech, Buckinghamshire, UK).

Invasion Assay

The BD BioCoat Matrigel Invasion Chamber (Becton Dickinson, Bedford, MA) contains an 8 μm pore size PET membrane with a Matrigel Basement Membrane Matrix. Twelve cell culture inserts and a 24-well multiwell companion plate were used for this experiment. Cells were knockdown miR-21, knockdown miR-21 negative control, and transfection reagent only (control), followed by incubation for 24 h. The cells were collected by tripsinization, followed by seeding in the internal chamber at 2 × 105 cells in medium containing 5 % FBS. The lower chamber was filled with medium containing 10 % FBS as a chemoattractant. Cells were incubated for 48 h at 37 °C in 5 % CO2 atmosphere. After incubation, the non-invading cells were removed from the upper surface of the membrane with a cotton-tipped swab. The cells on the lower surface of the membrane were stained with Diff-Quick stain, and then inserts were desiccated to air dry. The cells were counted under a microscope at 100× magnification. For the control cell count, cells that passed through a control chamber without Matrigel were counted. All experiments were completed in triplicate, and at least 4 fields/well were counted. The percentage of the cell count that passed through the Matrigel chamber to the control count that passed through a control chamber without Matrigel was calculated as the invasion index.

Statistical Analysis

Statistical analyses were performed using StatMateIV (AtmsCo., Tokyo, Japan). The categorical data were assessed by Fisher’s exact test. Continuous data are given as the mean ± standard deviation. Data sets were examined by one-way analysis of variance (ANOVA) followed by Scheffe’s post-hoc test. The disease-specific survival rate was calculated using the Kaplan-Meier method. Significance was evaluated using the log-rank test. P values less than 0.05 were considered significant.

Results

Correlation of MiR-21 Overexpression and Clinicopathological Features

MiR-21 were expressed in the cytoplasm as violet by ISH, and were expressed in almost all cancer tissues rather than normal tissues (Fig. 1). MiR-21 tended to be especially highly expressed in the invasive front of cancer tissues. MiR-21 overexpression was detected in 60 of 79 cases (75.9 %) and correlated with the pattern of invasion (P = 0.016), but not age, gender, T stage, N stage, or pathological differentiation (Table 1).

Fig. 1
figure 1

Representative miR-21 ISH in oral tongue SCC (200×). a H-E staining. b miR-21 ISH. C, cancerous tissue. N, normal tissue. Arrowhead, border between cancerous and normal tissues

Table 1 Correlation of miR-21 overexpression and clinicopathological features

Although patients without miR-21 overexpression showed a weak trend toward better survival, there was no significant relationship between miR-21 overexpression and survival (Fig. 2).

Fig. 2
figure 2

Disease-specific survival curve using Kaplan-Meier method

Determination of MiR-21 Target Gene

We used miRanda as a source in this study. For homosapiens, we found many target mRNAs from miR-21. The target mRNAs detected from the site contained many incorrect targets. We selected DKK2 as a Wnt/antagonist involved in tumor invasion. Moreover, DKK2 showed the highest mirSVR score (−0.72) among molecules involved in the Wnt pathway.

Relationship Between MiR-21 Overexpression and E-Cadherin, β-Catenin, or DKK2

Membranous immunostaining with E-cadherin and β-catenin was stronger in normal epithelium adjacent to the cancer tissue compared with the corresponding cancer areas (Fig. 3a). β-catenin and DKK2 immunostaining in cancer tissues were reversely correlated with miR-21 overexpression (Table 2; P < 0.001, respectively).

Fig. 3
figure 3

a Representative E-cadherin and β-catenin immunostaining (100×). Membranous immunostaining with E-cadherin and β-catenin was stronger in normal epithelium adjacent to cancer tissue compared with the corresponding cancer areas. b Representative miR-21 ISH, DKK2 and β-catenin immunostaining (100×). DKK2 and β-catenin immunostaining was reduced in areas with miR-21 overexpression

Table 2 Relationship between miR-21 overexpression and E-cadherin, β-catenin, or DKK2

DKK2 expression was recognized in the cytoplasm of normal tissues, and loss of DKK2 expression was observed in cancer cells. In particular, DKK2 immunostaining was reduced in the area with miR-21 overexpression. In addition, strong staining of miR-21 was correlated with the reduced staining of DKK2 and β-catenin (Fig. 3b).

It was found that the miR-21 status was significantly correlated with the DKK2/β-catenin immunohistochemical phenotype (Table 3, P < 0.001). Almost all combined DKK2-/β-catenin- cases showed miR-21 overexpression.

Table 3 Correlation of miR-21 overexpression and DKK2/β-catenin immunohistochemical phenotype

Knockdown of MiR-21 Significantly Decreased the Invasion Potential of SCC25 Cells

To determine the effect of miR-21 knockdown on the invasion potential, we transfected SCC25 cells with miR-21 knockdown probe, mock, and scrambled control probe. Mock and scrambled control probe transfection had no effect on miR-21 expression. A clear reduction in miR-21 was observed with the miR-21 knockdown probe (Fig. 4a), and was analyzed using the Matrigel invasion assay. Transfection with the miR-21 knockdown probe significantly decreased the invasive cells in SCC25 (P <0.01, Fig. 4b). The mean invasion index of cells transfected with the miR-21 knockdown probe was 12.5 %, whereas the means of the invasion index of cells treated with mock and transfected with the scrambled control probe were 58.2 % and 53.3 %, respectively.

Fig. 4
figure 4

a Effect of miR-21 knockdown probe on the expression of miR-21 was evaluated by RT-PCR of SCC25 cells. Cells were transfected for 72 h with Mock (transfection reagent alone), control probe, or miR-21 knockdown probe. b Knockdown of miR-21 significantly decreased the invasion index in SCC25 cells. Data are presented as the means of three separate experiments, each performed in triplicate. Bars, SD. *P < 0.01, compared with Mock and control probe, respectively. c Effect of miR-21 knockdown probe on the expression of DKK2. Western blot shows DKK2 expression

Knockdown of MiR-21 Significantly Decreased the Level of Total Cellular DKK2 in SCC25 Cells

We assessed the effect of miR-21 knockdown on the total cellular content of DKK2. Transfection with the miR-21 knockdown probe significantly decreased the level of total cellular DKK2 in SCC25 cells (Fig. 4c).

Discussion

MiR-21 is a key oncomir that is up-regulated in several cancers, including breast, pancreas, lung, gastric, prostate, colon, and head and neck cancers [1422]. Some researchers have demonstrated that miR-21 overexpression was involved in many characteristics of cancer, including proliferation, invasiveness, metastasis, and chemo-sensitivity [1721]. MiR-21 negatively regulates several targets and impacts carcinogenesis. In our study using in situ hybridization, we showed that the level of miR-21 expression was significantly higher in OTSCC tissues than adjacent normal oral tissues. Furthermore, miR-21 overexpression was significantly associated with the invasion pattern of OTSCC; however, miR-21 overexpression demonstrated no relationship with age, gender, TN stage, or differentiation. These results implied that miR-21 overexpression might play critical roles in OTSCC tumorigenesis and tumor invasiveness. A systemic review and meta-analysis showed that miR-21 overexpression did indeed result in the poor survival of patients with a variety of carcinomas [16]. Li et al. [25] reported that miR-21 would be a clinically relevant independent prognostic factor in OTSCC. In our ISH analyses, patients without miR-21 overexpression showed a weak trend toward better survival, although the statistical difference was not significant.

MiR-21 overexpression has been linked to increased tumor invasion [1922, 2630]. Recent studies indicated that several molecules, including phosphatase and tensin homolog deleted on chromosome ten (PTEN) [21, 29, 30], programmed cell death 4 (PDCD4) [19, 20], and matrix metalloproteinases inhibitors RECK [22], were targets of miR-21, suggesting that miR-21 is an important oncogenic miRNA closely related to tumor invasion. Han et al. [30] demonstrated that miR-21 can regulate the cell invasiveness of breast cancer via AKT and ERK1/2 pathways by targeting PTEN. Moreover, Asangani et al. [19] reported that tumor suppressor PDCD4 could be negatively regulated by miR-21 at the post-transcriptional level via a specific target site within the 3′-UTR in colorectal cancer; however, the effect of miR-21 on tumor invasiveness in OTSCC remains to be elucidated.

In this study, we showed that miR-21 overexpression is correlated with the DKK2-/β-catenin- immunohistochemical phenotype in OTSCC; therefore, we suggested that DKK2 expression would be down-regulated by miR-21 in OTSCC. The DKK family is composed of four members, DKK1-DKK4, which act as inhibitors of Wnt/β-catenin signaling [3133]. Among the DKK family, DKK2 is a putative Wnt/β-catenin signaling inhibitor that is generally down-regulated in human cancers, including ovarian cancer and renal cancer [33, 34]. DKK2 can function as either a Wnt agonist or antagonist, depending on the cellular context and the expressed amount of its binding partner low-density lipoprotein receptor-related protein 6 (LRP6) and its cofactor Kremen 2 [32]. Wnt/β-catenin signaling, transduced by LRP6 and Frizzled receptor complexes, leads to nuclear translocation of β-catenin and its interaction with TCF/LEF factors to regulate transcription [35]. Recently, some researchers reported that DKK2 inhibits tumor progression or invasion through the Wnt/β-catenin signaling pathway [33, 34]. Our results in this study suggested that miR-21inhibits tumor suppressor DKK2, activates the Wnt/β-catenin pathway and promotes OTSCC invasion.

Because our data using clinical samples suggested that miR-21 overexpression is related to the tumor invasion of OTSCC by targeting DKK2, we further evaluated whether miR-21 contributes to cell invasiveness by blocking its expression with a specific knockdown LNA probe. We observed that miR-21 knockdown decreased the invasion potential with up-regulated DKK2 in OTSCC cells. These results supported that miR-21 promotes OTSCC cell invasion via the Wnt/β-catenin pathway by targeting DKK2 (Fig. 5). In our study, we identified DKK2 as a marked miR-21 target because DKK2 showed the highest mirSVR score among molecules involved in the Wnt pathway. The MirSVR score is a new machine-learning method for ranking microRNA target sites by their down-regulation score, is calibrated to correlate with down-regulation, and can be interpreted as the empirical probability of target inhibition, leading to an intuitive choice of score threshold [36]. On the other hand, previous studies reported that miR-21 promotes tumor invasion through the β-catenin/STAT3 pathway by targeting RECK [22, 37]; therefore, not only the miR-21/DKK2/Wnt/β-catenin pathway has been implicated in the promotion of tumor invasion. Therefore, further studies are necessary to elucidate the molecular mechanism by which miR-21 modulates the Wnt/β-catenin pathway to promote OTSCC invasion.

Fig. 5
figure 5

Schematic drawing of the miR-21/DKK2/Wnt/β-catenin pathway

In summary, we found that miR-21 is overexpressed and associated with tumor invasion in OTSCC, and that miR-21 promotes OTSCC cell invasion via the Wnt/β-catenin pathway by targeting DKK2 in vitro. These results suggest that miR-21 may be a potential therapeutic target for OTSCC treatment.